About

What is VCSIP?
VCSIP is the Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function Study.
VCSIP is studying a simple approach to decrease breathing problems in infants born to women who can not quit smoking during pregnancy.
VCSIP will study the effect of vitamin C on infant’s lungs by measuring their lung function and monitoring the number of episodes of wheezing through 12 months of age.

Why is the VCSIP study important?
-Smoking during pregnancy is one of the most common causes for adverse outcomes for both mom and baby.
-Whenever possible pregnant women should quit smoking before or during pregnancy. However smoking is very addicting and sometimes it is difficult to quit. Data shows that about one half of women who smoke quit when they become pregnant and half of them do not quit.
-Smoking during pregnancy can affect how the baby’s lungs develop and lead to increased childhood breathing problems. These breathing problems lead to increased emergency room visits, missed school days, missed days of work for parents, and eventually some of the children will develop asthma.
-Researchers think that vitamin C may be a safe way to help protect the baby’s lungs during development from the effects of smoking during pregnancy but more studies are needed.

Publications
Vitamin C Supplementation for Pregnant Smoking Women and Pulmonary Function in Their Newborn Infants

Vist our FAQ Page for more information